Intra-cellular therapies mourns the passing of director, dr. richard lerner

New york, dec. 06, 2021 (globe newswire) -- intra-cellular therapies, inc. (nasdaq:itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, mourns the passing of one of our directors, richard lerner, md, a scientific leader who contributed many research discoveries and technologies that have had major impacts on science and medicine. dr. lerner served on the board of directors of intra-cellular therapies since the company's formation in 2002.
ITCI Ratings Summary
ITCI Quant Ranking